This is an automatically translated article.
Sunoxiplat 50 contains the active ingredient Oxaliplatin and other excipients with just enough drug content provided by the manufacturer. This drug belongs to the group of anti-cancer drugs and acts on the immune system.
1. What is Sunoxiplat 50?
Sunoxiplat 50 contains the active ingredient Oxaliplatin and other excipients with just enough drug content provided by the manufacturer. This drug belongs to the group of anti-cancer drugs and acts on the immune system.
1.1. Pharmacodynamics of the active ingredient Oxaliplatin Main active ingredient Oxaliplatin is a platinum-containing organic complex, which has antitumor and antiproliferative activity in various tumor types including colon and rectal cancer in humans. .
1.2. Pharmacokinetics of the active substance Oxaliplatin Nearly 15% of the dose of the active substance Oxaliplatin enters the general circulation after a 2-hour infusion. Meanwhile, the remaining 85% of the dose is rapidly distributed into tissues or excreted in the urine. This active substance is excreted mainly through renal elimination. 5 days after a single infusion of the active ingredient Oxaliplatin over a period of 2 hours, it is eliminated in urine and feces.
2. What disease is Sunoxiplat 50 used to treat?
What does Sunoxiplat 50 do? Sunoxiplat 50 is a prescription drug indicated for intravenous infusion in the adjuvant treatment of colon cancer patients whose primary tumor has been completely resected.
3. Usage and dosage of Sunoxiplat 50
Usage and dosage of Sunoxiplat 50 is as follows:
3.1. How to use the drug Sunoxiplat 50 Sunoxiplat 50 is indicated for intravenous use. Patients should strictly follow the instructions of the doctor and medical staff performing the infusion.
3.2. Subjects using the drug Sunoxiplat 50 Users can only use it when prescribed by the treating doctor and under the supervision of medical staff.
3.3. Dosage of Sunoxiplat 50 The recommended dose of Sunoxiplat 50 is as follows:
Dosage adjuvant treatment for people with rectal cancer: The total recommended duration of treatment is 6 months, equivalent to 12 cycles. cycle, every 2 weeks, according to the guidelines outlined below, for people with previously treated advanced colon-rectal cancer. Dose adjustment in patients with advanced colorectal cancer with or without prior treatment.
4. Undesirable effects of the drug Sunoxiplat 50
Undesirable effects of Sunoxiplat 50 commonly are:
Systemic: allergic hypersensitivity, loss of appetite, fever caused by infection, fatigue, abdominal pain, nausea, diarrhea, vomiting. Local reactions: appearance of skin abnormalities, reactions at the injection site, stomatitis. Otolaryngology reactions: rhinitis, nosebleeds. Eye reactions such as conjunctivitis, abnormal facial discharge, visual disturbances. Gastrointestinal reactions: constipation, altered taste, dyspepsia, gastrointestinal disease unspecified. Psychiatric reactions: insomnia, depression. You need to proactively notify the treating doctor of any unwanted effects that you encounter during the use of the drug so that the doctor and medical staff can promptly handle it.
5. Interactions of Sunoxiplat 50
Possible interactions of Sunoxiplat 50 during use are:
For people who took a single dose of Sunoxiplat 50 just before taking 5-fluorouracil, there was no change in the level of risk of 5-fluorouracil. .. When using Sunoxiplat 50 with foods or alcohol, beer, tobacco... because those foods and drinks contain other active ingredients, they can affect and cause antagonism or synergistic phenomena with this drug. You should carefully read the instructions for use or consult your doctor about the use of Sunoxiplat 50 with food, alcohol and tobacco.
6. Some notes when using Sunoxiplat 50
6.1. Contraindications of the drug Sunoxiplat 50 Do not use Sunoxiplat 50 for people with a history of allergy to the drug or other products containing platinum.
6.2. Use of Sunoxiplat 50 in pregnancy and lactation Pregnant women: It is necessary to warn users of the risk of harm to the fetus if they take Sunoxiplat 50 during pregnancy or become pregnant during use. medicine. Women of childbearing age should be warned to use contraception during treatment with Sunoxiplat 50 . Lactation: It is not known whether Oxaliplatin and its metabolites are excreted in human milk. This is because many drugs are now excreted in human milk and because of the risk of dangerous side effects in nursing infants from oxaliplatin. You need to be careful when deciding whether to stop breastfeeding or stop using Sunoxiplat 50 and need to consider the importance of the drug to the life of the mother. 6.3. How to store the drug Sunoxiplat 50 drug solution after mixing is stable physico-chemically for 48 hours at an average temperature of 2-8 degrees and 30 degrees. However, microbiologically, after mixing should be diluted into the infusion solution for immediate use. If not used immediately, this solution must be stored at 2-8 degrees for no more than 24 hours. Keep Sunoxiplat 50 out of the reach of children and away from pets. Before using Sunoxiplat 50, it is necessary to check the expiry date indicated on the product packaging, especially with medicines stored at home. Above is all information about the drug Sunoxiplat 50, patients need to carefully read the instructions for use, consult a doctor / pharmacist before use. Absolutely do not arbitrarily buy Sunoxiplat 50 to treat diseases at home, because there may be unwanted side effects on health.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
